Pegasus Biologics' DermADAPT Biomatrix wound dressing has been approved by the FDA for the local management of moderate to heavy exuding wounds, including partial- and full-thickness wounds, draining wounds, pressure ulcers, venous ulcers, chronic vascular ulcers, diabetic ulcers, trauma wounds, and surgical wounds.

The dressing is a biocompatible, highly organized type 1 collagen matrix. It's stable, strong, thin and conformable, easy to store, and available in two sizes (fenestrated and nonfenestrated versions). The product passes stringent sterility testing.

Studies suggest that the product forms a biologic scaffold that is resistant to enzymes, allowing controlled biodegradation and subsequent remodeling in the patient.

Source